Prot # 223AS302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center of the Safety and Efficacy of Dexpramipexole in Subjects with Amyotrophic Lateral Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date6/21/11 → 8/31/13

Funding

  • Quintiles, Inc. (Prot # 223AS302 // Prot # 223AS302)
  • Biogen Inc. (Prot # 223AS302 // Prot # 223AS302)